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Abstract: Chronic cocaine administration leads to catecholamine reuptake inhibition which enhances reward and motiva-
tional behaviors. Ventral Tegmental Area dopaminergic (VTA DA) neuronal firing is associated with changes in reward 
predictive signals. Acute cocaine injections inhibit putative VTA DA cell firing in vertebrates. Parthenolide, a compound 
isolated from the feverfew plant (Tanacetum parthenium), has been shown to substantially inhibit cocaine’s locomotion 
effects in a planarian animal model (Pagán et al., 2008). Here we investigated the effects of parthenolide on the spontane-
ous firing activity of putative VTA DA neurons in anesthetized male rats (250-300g). Single-unit recordings were  
analyzed after intravenous (i.v.) parthenolide administration followed by 1mg/kg i.v. cocaine injection. Results showed 
that parthenolide at 0.125 mg/kg and 0.250mg/kg significantly blocked cocaine’s inhibitory effect on DA neuronal firing 
rate and bursting activity (p< 0.05, two way ANOVA). We propose that parthenolide might inhibit cocaine’s effects  
on VTA DA neurons via its interaction with a common binding site at monoamine transporters. It is suggested that  
parthenolide could have a potential use as an overdose antidote or therapeutic agent to cocaine intoxication.  
Keywords: Cocaine, parthenolide, ventral tegmental, dopamine, firing activity. 
INTRODUCTION 
 The mesocorticolimbic circuit functions as the center for 
reward and motivation [1]. The Ventral Tegmental Area 
(VTA) forms part of this circuit, and is identified with modu-
lating want and motivation [2]. VTA dopaminergic neuronal 
firing is associated with changes in reward predictive signals 
[3]. During chronic cocaine abuse, catecholamine reuptake 
mechanisms are inhibited, causing an increase in neuro-
transmitters at the synapse [4]. This increased concentration 
of dopamine, serotonin, or norepinephrine can have lasting 
effects in the form of neuroadaptations, such as enhanced 
reward and motivational behaviors, and serious short term 
effects such as cardiac arrest in susceptible individuals. 
 The purpose of this study was to characterize the effect of 
the drug known as parthenolide, a compound isolated from 
the feverfew plant (Tanacetum parthenium), on the rat ani-
mal model. Studies have shown that parthenolide has potent 
anti-inflammatory effects, but recent evidence suggests a 
potential blockade action on cocaine’s effects in an inverte-
brate animal model [5, 6]. Behavioral evidence in planarians 
supports that parthenolide can bind to catecholamine  
reuptake transporters without impairing function, and this 
binding prevents cocaine’s effect by allosteric competition 
[4].  
 Dopamine (DA) cells in the VTA have an important role 
in pleasure-seeking behavior modulation [7]. They are also 
innervated by noradrenergic afferents and are thus modulated 
in part by norepinephrine [8]. Acute cocaine administration  
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can be observed by the inhibition of VTA DA cell activity 
[9]. Thus, we tested parthenolide’s effect on the inhibition 
produced by cocaine in the rat VTA DA cells when both are 
injected intravenously. 
MATERIALS AND METHODS 
Animal Preparation 
 Sprague-Dawley male rats (250-–300 g) were used as the 
experimental subjects for all of these studies. The animals 
were housed two per cage in the colony room and main-
tained at a constant temperature and humidity with a 12-hr 
hour light/dark cycle. They were randomly assigned to the 
groups before the study begins. All efforts were made to 
minimize animal discomfort and to limit the number of ani-
mals used in this project. The procedures were approved by 
the Universidad Central del Caribe Institutional Animal Care 
and Use Committee. 
 Animals were anesthetized with chloral hydrate (400 
mg/kg, i.p.). Afterwards the animal was placed in the stereo-
taxic apparatus for electrophysiological recordings. Rats 
were secured in a stereotaxic apparatus in the flat skull posi-
tion [6]. Body temperature was maintained (37 °C) with a 
thermostatically controlled heating pad. A craniotomy was 
performed and electrodes were lowered into the VTA. 
Stereotaxic coordinates for the ventral tegmental area (VTA) 
were 3.0 to 3.4 mm anterior to lambda, 0.4 to 1.0 mm  
medial/lateral, and 6.0 to 8.0 mm dorsal/ventral from the 
cortical surface. 
 Drugs were administered intravenously via a jugular 
catheter. Parthenolide (Tocris) was diluted with 20% 
DMSO/80% dH2O until a concentrations of 0.125 mg/kg or 
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0.250mg/kg were achieved. Cocaine was used in a dose of 
1mg/kg.  
Extracellular Recording 
 Single-barrel microelectrodes filled with Pontamine Sky 
Blue Solution 2% (PSB), tip diameter 3-6 micrometers, were 
used to record single unit activity in the VTA. The recording 
microelectrode was slowly advanced 7-8 mm until single 
unit activity correspondent of waveform parameters for a 
dopaminergic cell were observed (characteristically low (4-5 
spikes/sec) firing rate, large action potential amplitude, and 
1.1ms wavelength from peak to negative trough). Neuronal 
activity was amplified (DAM 80 amplifier, World Precision 
Instruments) and sent to an interface for digitalization. The 
interface’s output was fed to a computer for on-line wave-
form display (Spike 2, Cambridge Electronic Design, UK).  
Histological Verification of Recording Sites 
 The last recording site in an experiment was marked by 
iontophoresis of pontamine sky blue (2%, -7 A for 10 min-
utes). The animal was euthanized, the brain removed and put 
in 8% formaline and stored in a refrigerator. The location of 
the electrodes was determined during microscopic examina-
tion of Nissl-stained, coronal brain sections, cut at 40- to 50-
micron intervals in a cryostat. 
Data Analysis 
 Data was analyzed using Spike2 bundled software with 
Principal Component Analysis (PCA) for spike isolation and 
data mining. Microsoft Excel and GraphPad Prism 4.5 soft-
ware were used for statistical analysis. Two way repeated 
measures ANOVA with a Bonferroni post hoc test were em-
ployed. 
RESULTS 
 Fig. (1) shows the effects of cocaine and parthenolide 
administration on VTA DA firing rate. Intravenous cocaine 
injections induced an inhibition in firing activity that peak 
approximately 9-12 minutes after the injection. Parthenolide, 
(0.125 mg/kg or 0.250 mg/kg intravenously), was adminis-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Effects of parthenolide on VTADA neuronal firing rate. Parthenolide administration (0.125 mg/kg, i.v. or 0.250 mg/kg, i.v.) blocked 
cocaine’s (1 mg/kg, i.v.) inhibitory actions on VTADA firing activity. (Two way ANOVA, P<0.0001). 
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tered before a single cocaine (1mg/kg,i.v.) injection. The 
results showed that cocaine’s inhibitory action was not af-
fected when animals were pre-injected with saline. On the 
other hand, cocaine’s inhibitory action was blocked when 
rats were pre-injected by either dose of parthenolide, 
(0.125mg/kg or 0.250 mg/kg). These results were determined 
highly significant by a repeated measures two-way ANOVA 
[F(18,189)  4.05, p < 0.0001].  
 When doses were compared, parthenolide at 0.125 
mg/kg, seems to be more effective at inhibiting cocaine’s 
action, although the difference between 0.250 mg/kg and 
0.125 mg/kg was not statistically significant.  
 Bursting analysis was conducted to investigate whether 
acute cocaine injections induced changes in the firing pattern 
of VTA DA neurons. Fig. (2) shows the distribution of burst-
ing events in time as percent of the total bursting activity. 
The significant difference [F(18,189)  6.42, p < 0.0001] of 
bursting activity during the baseline period between cocaine 
and parthenolide treated groups (75.39% cocaine group vs 
13.02% and 20.86% in parthenolide 0.125 mg/kg and 0.250 
mg/kg, respectively) indicates that greater part of the cocaine 
group’s bursting events occurred before cocaine administra-
tion. Thus, acute intravenous cocaine administration com-
pletely inhibited bursting activity in dopaminergic VTA neu-
rons. However, animals pre-injected with parthenolide 
(0.125 mg/kg or 0.250 mg/kg) maintained a relatively ho-
mogenous distribution of bursting activity. This suggests that 
parthenolide administration also seems to block cocaine’s 
inhibitory effects on bursting activity in VTA DA neurons. 
 The mean number of spikes per burst analysis showed 
that the 0.250 mg/kg parthenolide group demonstrate a  
decreased number of spikes after 15 minutes post injection 
which recovered around 30 minutes after injection 
[F(18,189)  2.41, p < 0002]. The latter effect was not due to 
changes in the number of bursting activity as shown in Fig. 
(2). On the other hand, the 0.250 mg/kg dose induced a sig-
nificant decrease in burst duration at 21 and 24 minutes after 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Distribution of bursting events in time as percent of the total bursting activity. Cocaine administration almost totally inhibited burst-
ing activity of VTADA cells. Most part of cocaine’s bursting events occurred before cocaine administration. Animals previously injected 
with parthenolide maintained a relatively homogeneous distribution of bursting activity. There was a significant difference in bursting activ-
ity between cocaine and parthenolide treated groups (Two way ANOVA, P<0.0001). 
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injection [F(18,189)  2.17, p < 0.005] which might account 
for the decreased number of spikes observed. 
DISCUSSION 
 The present study demonstrates that parthenolide admini-
stration blocks the acute cocaine’s action on VTA DA neu-
ronal firing activity. Similar to the behavioral results pub-
lished by Pagán et al. 2008, systemic administration of 
parthenolide prior to a cocaine injection blocked cocaine-
induced firing rate inhibition and bursting activity. Both dos-
ages of parthenolide were effective in blocking cocaine’s 
action on putative VTA DA cells. This finding was consis-
tent throughout the experiment.  
 The neurochemical action of cocaine is to inhibit the re-
uptake mechanisms of catecholamines causing an increase in 
neurotransmitters at the synapse [4]. It has been shown that 
acute administration of psychostimulant drugs such as co-
caine decrease VTA DA neuronal activity. This action is 
likely due to the fact that psychostimulants drugs enhance 
extracellular concentrations of dopamine at the somatoden-
dritic area resulting in an activation of impulse-regulating 
autoreceptors thus inhibiting neuronal firing [10, 11]. 
Changes in VTA DA cell activity while the drug of abuse is 
onboard are important for triggering the enhancement of 
neuronal activity observed after withdrawal from drug expo-
sure. Eventually this increase in VTA neuronal firing is criti-
cal in the development of cocaine sensitization [12]. 
 Parthenolide has been shown to play a role in other 
mechanisms, such as inhibiting the NF-B cell signaling 
pathway [13], suggesting a drug’s interaction with other 
mechanisms that might not be in operation at lower dosages. 
It is likely that parthenolide at a dose of 0.125 mg/kg is more 
effective at exerting its effect on cocaine’s mechanism of 
action. Interestingly, neurons treated with parthenolide at 
0.250 mg/kg had a reduction in burst duration, which corre-
lated with a diminution in the number of spikes per burst. 
Further studies including dose response curves could serve to 
clear this issue.  
 Previous experiments [4] showed that cocaine and 
parthenolide do not interact directly; instead, their effect 
seems to be localized to a common binding site on the pla-
narian nervous system. Based on this previous study and on 
the work presented here, we propose that parthenolide ac-
tively competes with cocaine, displacing the drug from in-
hibiting the transporter and allowing it to function normally. 
These observed behavioral and neurophysiological interac-
tions of parthenolide and cocaine are consistent with the idea 
of parthenolide acting as a dopamine-sparing, cocaine an-
tagonist (DSCA) [14]. DSCA’s are hypothesized to bind to 
the dopamine-cocaine sites on the dopamine transporter in 
such a way that block cocaine’s interaction with the trans-
porter, while leaving dopamine interactions with the trans-
porter unaffectaed [10]. Binding studies, could further clarify 
parthenolide’s mechanism of action. A positive result could 
further clarify parthenolide’s role in the inhibition of  
cocaine’s effect.  
 Since high concentrations of cocaine acutely can be 
harmful or even lethal to an organism, a compound that acts 
at a common binding site displacing cocaine from it could 
have utility as an overdose antidote or therapeutic agent.  
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